KR20140139501A - 2-아미노-3-(4-브로모벤조일)페닐아세트산 함유 수성 조성물 - Google Patents

2-아미노-3-(4-브로모벤조일)페닐아세트산 함유 수성 조성물 Download PDF

Info

Publication number
KR20140139501A
KR20140139501A KR1020147025807A KR20147025807A KR20140139501A KR 20140139501 A KR20140139501 A KR 20140139501A KR 1020147025807 A KR1020147025807 A KR 1020147025807A KR 20147025807 A KR20147025807 A KR 20147025807A KR 20140139501 A KR20140139501 A KR 20140139501A
Authority
KR
South Korea
Prior art keywords
aqueous composition
bromobenzoyl
amino
polyoxyethylene sorbitan
sorbitan fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
KR1020147025807A
Other languages
English (en)
Korean (ko)
Inventor
다카시 모리모토
히로유키 아사다
교헤이 다카하시
도모유키 오카모토
Original Assignee
산텐 세이야꾸 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 산텐 세이야꾸 가부시키가이샤 filed Critical 산텐 세이야꾸 가부시키가이샤
Publication of KR20140139501A publication Critical patent/KR20140139501A/ko
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
KR1020147025807A 2012-03-28 2013-03-28 2-아미노-3-(4-브로모벤조일)페닐아세트산 함유 수성 조성물 Abandoned KR20140139501A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012073181 2012-03-28
JPJP-P-2012-073181 2012-03-28
PCT/JP2013/059211 WO2013147000A1 (ja) 2012-03-28 2013-03-28 ２－アミノ－３－（４－ブロモベンゾイル）フェニル酢酸含有水性組成物

Publications (1)

Publication Number Publication Date
KR20140139501A true KR20140139501A (ko) 2014-12-05

Family

ID=49260248

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147025807A Abandoned KR20140139501A (ko) 2012-03-28 2013-03-28 2-아미노-3-(4-브로모벤조일)페닐아세트산 함유 수성 조성물

Country Status (9)

Country Link
JP (1) JP5922609B2 (enExample)
KR (1) KR20140139501A (enExample)
CN (1) CN104203224A (enExample)
IN (1) IN2014DN07767A (enExample)
MY (1) MY170840A (enExample)
PH (1) PH12014502171A1 (enExample)
SG (1) SG11201405837YA (enExample)
TW (1) TWI604858B (enExample)
WO (1) WO2013147000A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016199854A1 (ja) * 2015-06-10 2016-12-15 参天製薬株式会社 点眼剤、及び点眼剤防腐効力維持方法
CN111712238A (zh) * 2017-12-14 2020-09-25 参天制药株式会社 含有2-氨基-3-（4-溴苯甲酰基）苯乙酸或其盐的滴眼剂
CN114224830A (zh) * 2021-12-24 2022-03-25 辰欣药业股份有限公司 一种单剂量无抑菌剂的眼用制剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002308764A (ja) * 2001-02-09 2002-10-23 Taisho Pharmaceut Co Ltd 眼科用医薬組成物
US7829544B2 (en) * 2003-11-14 2010-11-09 Senju Pharmaceutical Co., Ltd. Aqueous solution preparation containing aminoglycoside antibiotic and bromfenac
CN1823754A (zh) * 2006-03-28 2006-08-30 卢秀莲 溴芬酸钠滴眼液及其制备方法
CN101313899B (zh) * 2007-06-01 2012-02-29 北京德众万全药物技术开发有限公司 一种含有溴芬酸钠的眼用药物组合物
WO2009105534A2 (en) * 2008-02-21 2009-08-27 Ista Pharmaceuticals Ophthalmic nsaids as adjuvants
CN101322683B (zh) * 2008-07-30 2013-01-16 浙江三叶药业有限公司 一种含有溴芬酸钠水合物的眼用凝胶剂及其制备方法
BR112013018025A2 (pt) * 2011-01-18 2020-10-27 Senju Pharmaceutical Co., Ltd composição de bromfenac líquida aquosa método para reforçar a eficácia conservante de uma solução aquosa
JP6012231B2 (ja) * 2011-04-08 2016-10-25 ロート製薬株式会社 ブロムフェナク含有組成物

Also Published As

Publication number Publication date
CN104203224A (zh) 2014-12-10
IN2014DN07767A (enExample) 2015-05-15
JP5922609B2 (ja) 2016-05-24
JP2013227300A (ja) 2013-11-07
MY170840A (en) 2019-09-10
TWI604858B (zh) 2017-11-11
WO2013147000A1 (ja) 2013-10-03
TW201343197A (zh) 2013-11-01
PH12014502171A1 (en) 2014-12-10
SG11201405837YA (en) 2014-11-27

Similar Documents

Publication Publication Date Title
US11439652B2 (en) Ophthalmic aqueous composition
CN105828817B (zh) 含有吡啶基氨基乙酸化合物和聚氧乙烯蓖麻油的药物组合物
KR102607126B1 (ko) 안과용 조성물
TW201609097A (zh) 含吡啶基胺基乙酸化合物之醫藥組成物
KR20140139501A (ko) 2-아미노-3-(4-브로모벤조일)페닐아세트산 함유 수성 조성물
CN103608000B (zh) 含有透明质酸或其盐以及丙二醇的滴眼液
CN114630669B (zh) 稳定的医药组合物
WO2017175098A1 (en) Stable liquid pharmaceutical formulations of bendamustine
CN105451731A (zh) 含有经稳定化的2－氨基－3－(4－溴苯甲酰基)苯乙酸的水性组合物
HK1220393B (zh) 含有经稳定化的2-氨基-3-(4-溴苯甲醯基)苯乙酸的水性组合物
JP5253775B2 (ja) ラタノプロスト点眼剤
JP6817877B2 (ja) ドルゾラミド、高分子およびホウ酸を含有する医薬組成物
JP2007016024A (ja) ロフルミラスト点眼液
JP5460996B2 (ja) 眼科用剤
JP4832015B2 (ja) オキシグルタチオン含有水溶液
HK40074840A (en) Stable pharmaceutical composition
HK40074840B (zh) 稳定的医药组合物
HK1235711A1 (en) Ophthalmic aqueous composition
HK1235711B (en) Ophthalmic aqueous composition

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20140916

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20160517

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20170217

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20171101

PC1904 Unpaid initial registration fee